Clinical TrialsSearch results
Number of results: 2443
Other
- A PHASE I/II STUDY OF ATEZOLIZUMAB 1680 MG EVERY 4 WEEKS IN PATIENTS WITH ADVANCED SOLID TUMOR
- Advanced Solid Tumors
- Shunichiro Iwasawa
- 2022-06-21
Other
- A phase I/II study of hepatic arterial 5-flurouracil (5FU) combined with intravenous irinotecan hydrochloride (CPT-11) for metastatic colorectal cancer isolated in the liver. (JCOG 0208-DI)
- Metastatic colorectal cancer isolated in the liver
- Japan Clinical Oncology Group(JCOG)
- 2005-08-08
Other
- A Phase I/II study of JR-031 for the patients of standard primary treatment-refractory acute graft-versus-host disease (acute GVHD) after hematopoietic stem cell transplantation
- Standard primary treatment-refractory acute GVHD
- JCR pharmaceuticals Co.,Ltd
- 2009-02-19
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0203)
- Unresectable malignant lung tumor.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase I/II study of percutaneous vertebroplasty (JIVROSG-0202)
- Malignant vertebral bone tumor.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)
- Unresectable hypervascular hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2007-09-01
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase I/II study of UMN-0501 (prepandemic recombinant hemagglutinin influenza vaccine) administrated intramuscularly in healthy, 20 to 40 years of age, male volunteers investigating it's safety, tolerability and immunogenicity. (single center, ascending doses, open label)
- Prevention of influenza pandemic
- UMN Pharma Inc.
- 2008-06-18
Other
- A phase I/II study of uterine artery embolization using gelatine sponge for symptomatic uterine leiomyoma (JIVROSG-0302)
- Symptomatic uterine leimoyoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05